Jazz Pharmaceuticals JAZZ Change in Income Taxes
Change in Income Taxes at other companies
Other financials
Where this comes from
Reported directly by Jazz Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable.
The official record: Jazz Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Jazz Pharmaceuticals's change in income taxes.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Jazz Pharmaceuticals's change in income taxes?
- Jazz Pharmaceuticals (JAZZ) reported change in income taxes of $37.4M in Q1 2026.
- How has Jazz Pharmaceuticals's change in income taxes changed year-over-year?
- Jazz Pharmaceuticals's change in income taxes increased by 187.7% year-over-year, from $13M to $37.4M.
- What does change in income taxes mean?
- The change in the amount of income tax owed to or refundable from tax authorities.
- How do you interpret change in income taxes?
- An increase in taxes payable is a source of cash, while a decrease is a use of cash.
- How does change in income taxes compare across companies?
- Standard across all industries; highly dependent on jurisdictional tax laws and payment schedules.